Cytoprotective action of 17β-oestradiol against iron-induced hepatic oxidative stress in vitro

Bulletin of the Veterinary Institute in Pulawy

Volumn 54, Issue 2, 2010, Pages 259-263

  Wójcik, Marta ^a   Kosior Korzecka, Urszula ^a   Bobowiec, Ryszard ^a  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

17 Oestradiol; Haptoglobin; Hepatocytes; Iron; Oxidative stress

Indexed keywords

EID: 77954608070     PISSN: 00424870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ana M., Leal M., Ruiz-Larrea B., Martinez M., Lacort M.: Cytoprotective action of estrogens against tert-butyl hydroperoxide-induced toxicity in hepatocytes. Biochem Pharmac 1998, 55, 1463-1469.
2. Barone M., Ladisa R., Di Leo A., Spano D., Francioso D., Aglio V., Amoruso A., Francavilla A., Iolascon A.: Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Clip1) and 27 (Kip1). Dig Dis Sci 2006, 51, 580-586.
3. Barth A., Landmann G., Liepold K., Zapf H., Müller D., Karge E., Klinger W.: Influence of oestrogens on formation of reactive species in liver microsomes of differently aged male Wistar rats. Exp Toxic Pathol 1999, 51, 282-288.
4. Brambilla G., Ballerini A., Civitareale C., Fiori M., Neri B., Cavallina R., Nardoni A., Giannetti L.: Oxidative stress as a bio-marker of estrogen exposure in healthy veal calves. Anal Chimic Acta 2003, 483, 281-288.
5. Brouwers A., Langlois M., Delanghe J., Billiet J., De Buyzere M., Vercaemst R., Rietzschel E., Bernard D., Blaton V.: Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 2004, 176, 189-195.
6. Brown K.E., Broadhurst K.A., Mathahs M., Weydert J.: Differential expression of stress-inducible proteins in chronic hepatic iron overload. Toxicol Appl Pharmacol 2007, 223, 180-186.
7. Butterworth M., Lau S.S., Monks T.J.: 2-hydroxy-4-glutathion-S-yl-17ß-estradiol and 2-hydroxy-1-glutathion-S-yl-17ß-estradiol produce oxidative stress and renal toxicity in animal model of 17ß-estradiol-mediated nephrocarcinogenicity. Carcinogenesis 1998, 19, 133-139.
8. Cantoni L., Di Padova C., Rizzardini M., Dal Fiume D., Graziani A., Rovagnati P., Tritapepe R.: Effects of iron overload on bile secretion and hepatic porphyrin metabolism in etnihyl estradiol-treated rats. Toxicology 1986, 38, 187-196.
9. Emerit J., Beaumont C., Trivin F.: Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 2001, 55, 333-339.
10. Farinati F., Cardin R., Bortolami M., Grottola A., Manno M., Colantoni A., Villa E.: Estrogens receptors and oxidative damage in the liver. Mol Cell Endocrinol 2002, 193, 85-88.
11. Furutani T., Hino K., Okuda M., Gondo T., Nishina S., Kitase A., Korenaga M., Xiao S. Y., Weinman S.A., Lemon S.M., Sakaida I., Okita K.: Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 2006, 130, 2087-2098.
12. Klinger W., Lupp A., Karge E., Baumbach H., Eichhorn F., Feix A., Füldner F., Gernhardt S., Knels L., Kost B., Mertens G., Werner F., Oettel M., Römer W., Schwarz S., Elger W., Schneider S.: Estradiol, testosterone, dehydroepiandrosterone and androstenedione: novel derivatives and enantiomers. Interactions with rat liver microsomal cytochrome P450 and antioxidant/radical scavenger activities in vitro. Toxicol Lett 2002, 128, 129-144.
13. Koroxenidou L., Ohison L.C., Porsch Hällström I.: Long-term 17(-ethinyl estradiol treatment decreases cyclin E and cdk2 expression, reduces cdk2 kinase activity and inhibits S phase entry in regenerating rat liver. J Hepatol 2005, 43, 478-484.
14. Lavery K., Gabler C., Day J., Killian G.: Expression of haptoglobin mRNA in the liver and oviduct during the oestrous cycle of cows (Bos taurus). Anim Reprod Sci 2004, 84, 13-26.
15. Ledwożyw A., Michalak J., Ste{ogonek}pień A., Ka{ogonek}dziołka A.: The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986, 155, 275-284.
16. Liehr J.G., Roy D., Ari-Ulubelen A., Bui Q.D., Weisz J., Strobel H.W.: Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catecholestrogens and their redox cycling: implications for carcinogenesis. J Steroid Biochem 1990, 5, 555-560.
17. Markides C.S.A., Roy D., Liehr J.G.: Concentration dependence of prooxidant and antioxidant properties of catecholestrogens.: Archiv Biochem Biophys 1998, 360, 105-112.
18. Martínez R., Quintana K., Navarro R., Martín C., Hernández M. L., Aurrekoetxea I., Ruiz-Sanz J.I., Lacort M., Ruiz-Larrea M.B.: Pro-oxidant and antioxidant potential of catecholestrogens against ferrylmyoglobin-induced oxidative stress. Biochim Biophys Acta 2002, 1583, 167-175.
19. Owen J.A., Carew J.P., Cowling D.C., Hoban J.P., Smith H.: Serum haptoglobins in megaloblastic anaemia. British J Haematol 2008, 6, 242-249.
20. Purdy R.H., Moore jr P.H., Williams M.C, Goldzieher J.W., Paul S.M.: Relative rates of 2-and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. Febs Lett 1982, 138, 40-44.
21. Roy D., Liehr J.G.: Estrogen, DNA damage and mutations. Mutat Res 1999, 424, 107-115.
22. Thibodeau P.A., Kachadourian R., Lemay R., Bisson M., Day B.J., Paquette B.: In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem Mol Biol 2002, 81, 227-236.
23. Van Vierberghe H., Langlois M., Delanghe J.: Haptoglobin polymorphism and iron homeostasis in health and disease. Clin Chim Acta 2004, 345, 35-42.
24. Wójcik M., Bobowiec R., Martelli F.: Effect of carotenoids on in vitro proliferation and differentiation of oval cells during neoplastic and non-neoplastic injures in rats. J Physiol Pharmacol 2008, 59, 203-213.